Search details
1.
Improved time-of-flight range acquisition technique in underwater lidar experiments.
Appl Opt
; 54(18): 5715-25, 2015 Jun 20.
Article
in English
| MEDLINE | ID: mdl-26193020
2.
Resolution enhancement in active underwater polarization imaging with modulation transfer function analysis.
Appl Opt
; 54(11): 3294-302, 2015 Apr 10.
Article
in English
| MEDLINE | ID: mdl-25967316
3.
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.
Nat Commun
; 15(1): 1199, 2024 Feb 08.
Article
in English
| MEDLINE | ID: mdl-38331912
4.
Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World).
J Thorac Cardiovasc Surg
; 2024 Feb 10.
Article
in English
| MEDLINE | ID: mdl-38342430
5.
Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis via an ommaya reservoir.
Front Oncol
; 12: 1060575, 2022.
Article
in English
| MEDLINE | ID: mdl-36713576
6.
Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
EBioMedicine
; 82: 104165, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35901658
7.
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib.
Transl Oncol
; 14(9): 101163, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34192651
8.
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers.
Sci Adv
; 7(21)2021 05.
Article
in English
| MEDLINE | ID: mdl-34138742
9.
Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma.
J Immunother Cancer
; 8(2)2020 10.
Article
in English
| MEDLINE | ID: mdl-33115941
10.
TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer.
Cancer Immunol Res
; 8(1): 146-154, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31719056
11.
Refined Stratification Based on Baseline Concomitant Mutations and Longitudinal Circulating Tumor DNA Monitoring in Advanced EGFR-Mutant Lung Adenocarcinoma Under Gefitinib Treatment.
J Thorac Oncol
; 15(12): 1857-1870, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32916309
12.
Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors.
J Thorac Oncol
; 15(4): 556-567, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31843683
13.
Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer.
J Immunother Cancer
; 7(1): 198, 2019 07 26.
Article
in English
| MEDLINE | ID: mdl-31349879
14.
Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
Cancer Res
; 79(1): 7-20, 2019 01 01.
Article
in English
| MEDLINE | ID: mdl-30389703
15.
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.
JAMA Oncol
; 5(5): 696-702, 2019 May 01.
Article
in English
| MEDLINE | ID: mdl-30816954
16.
Prediction of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer by Serum Metabolomic Profiling.
Clin Cancer Res
; 24(9): 2100-2109, 2018 05 01.
Article
in English
| MEDLINE | ID: mdl-29437793
17.
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 18(1): 85-91, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27461774
18.
Anaplastic Lymphoma Kinase Variants and the Percentage of ALK-Positive Tumor Cells and the Efficacy of Crizotinib in Advanced NSCLC.
Clin Lung Cancer
; 17(3): 223-31, 2016 05.
Article
in English
| MEDLINE | ID: mdl-26454342
19.
Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancer.
Int J Biol Markers
; 31(2): e144-52, 2016 May 28.
Article
in English
| MEDLINE | ID: mdl-26689248
20.
The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma.
J Thorac Dis
; 7(9): 1630-6, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26543611